Glaxo Receives Positive Opinion On Eperzan For Type 2 Diabetes Treatment
LONDON (Alliance News) - Pharmaceuticals giant GlaxoSmithKline PLC said Friday that it had received a recommendation for marketing authorisation for its Eperzan treatment for type 2 diabetes from the European Medicines Agency's Committee for Medical Products for Human Use. The recommendatio Read More